Developed by Glaukos, the iDose TR (travoprost intraocular implant) 75 mcg is a new, FDA-approved treatment that is designed ...
Ophthalmologists discuss how advanced imaging, MIGS, and home monitoring are reshaping decision-making in complex glaucoma ...
About 3 million people in the United States have glaucoma, and it’s the second leading cause of blindness worldwide, according to the Centers for Disease Control and Prevention. While there is no cure ...
Scientists at Mizzou have identified two small molecules, agmatine and thiamine, that could both reveal and fight glaucoma.
A research team reveals the fine mechanisms behind the major vascular defects observed in glaucoma patients and identifies new therapeutic targets. Reduced blood flow and impaired neurovascular ...
Glaucoma is a group of diseases that damage the eye's optic nerve and can result in vision loss and even blindness. About 3 million Americans have glaucoma, and it's the second leading cause of ...
Founded to accelerate innovation in glaucoma treatment, Glaucoma 360 is GRF’s signature event and one of the vision community’s most anticipated annual gatherings. The three-day program features a ...
SIOUX FALLS, SD – November 04, 2025 – PRESSADVANTAGE – Glaucoma remains one of the leading causes of blindness in the United States, often progressing silently until vision loss has already occurred.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback